Day: April 20, 2025

Top Stocks To Watch

3 Software Stocks To Buy Now

Thumzup Media Corporation (TZUP) Thumzup Media is a digital marketing platform that pays users to promote brands on social media. Growth is driven by rising demand for micro-influencer campaigns, local brand adoption, and user engagement. Its platform offers a scalable model for grassroots advertising. Chart Electronic Arts Inc. (EA) Electronic Arts develops and publishes interactive […]

Read More
Trending Ideas

2 Stocks Positioned for a Boom in Global Ride and Booking Platforms

Uber Technologies, Inc. (UBER) Uber operates a global platform offering ride-sharing, food delivery, and freight services. Growth is fueled by urban mobility demand, digital convenience, and expansion into new verticals. The company continues to innovate with autonomous vehicles, subscription models, and partnerships to enhance customer value. Chart MakeMyTrip Limited (MMYT) MakeMyTrip is an online travel […]

Read More
Trade Of The Day

CuriosityStream (CURI): Educational Partnerships Gain Traction

CuriosityStream Inc. (CURI) CuriosityStream Inc. is a global streaming service that delivers factual and educational programming across science, nature, history, and technology. Founded by Discovery Channel’s John Hendricks, the platform offers original and licensed content to subscribers in over 175 countries. Its mission is to inspire lifelong learning through high-quality, ad-free documentaries and series targeted […]

Read More
Market Movers

Celsius Holdings (CELH): Gym and Grocery Penetration Expands

Celsius Holdings, Inc. (CELH) Celsius Holdings, Inc. develops, markets, and sells fitness energy drinks that are formulated to accelerate metabolism and burn body fat. Its flagship product line, CELSIUS, targets active consumers looking for performance-based beverages with functional benefits. With zero sugar and clinically proven ingredients, CELSIUS has carved out a strong niche in the […]

Read More
Market Movers

Soleno Therapeutics (SLNO): Biotech With a Focused Strategy

Soleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of rare diseases with high unmet need. Its lead candidate, DCCR (diazoxide choline extended-release), is being developed for the treatment of Prader-Willi syndrome (PWS), a complex genetic disorder with no FDA-approved treatment for its most severe symptoms. Soleno aims […]

Read More